Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,493 papers from all fields of science
Search
Sign In
Create Free Account
PK 8165
Known as:
PK-8165
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
pipequaline
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Etude des propriétés stimulantes de la pipequaline (PK-8165), un agoniste partiel des benzodiazépines, chez le volontaire sain
R. Frenckell
,
M. Scharres
,
M. Ansseau
,
D. Bonnet
1987
Corpus ID: 148080683
1986
1986
The ability of PK 8165, a quinoline derivative, to reduce responses to a stressful situation in a double-blind study in man
J. Willer
,
R. V. Frenkell
,
D. Bonnet
,
G. Fur
Neuropharmacology
1986
Corpus ID: 42473917
1984
1984
Pharmacological evidence that PK 8165 behaves as a partial agonist of brain type benzodiazepine receptors.
J. Mizoule
,
J. Rataud
,
+7 authors
M. Dubroeucq
Archives internationales de pharmacodynamie et de…
1984
Corpus ID: 21855021
PK 8165, a new quinoline derivative, has a good affinity for brain type benzodiazepine binding sites and an anticonflict activity…
Expand
1984
1984
The quinolines PK 8165 and PK 9084 possess benzodiazepine-like activity in vitro but not in vivo
P. Keane
,
J. Simiand
,
M. Morre
Neuroscience Letters
1984
Corpus ID: 5944885
1984
1984
Behavioural effects of PK 8165 that are not mediated by benzodiazepine binding sites
S. File
,
S. Pellow
Neuroscience Letters
1984
Corpus ID: 37636296
1982
1982
PK-8165 and PK-9084
J. Castaǹer
,
F. McGillion
1982
Corpus ID: 76261150
1982
1982
The effect of GABA on in vitro binding of two novel non-benzodiazepines, PK 8165 and CGS 8216, to benzodiazepine receptors in the rat brain.
M. Morelli
,
K. Gee
,
H. Yamamura
Life Science
1982
Corpus ID: 46436541
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE